Healionics Corporation
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
Mar 2030
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Mar 24, 2027The maintenance fee for Corrugated Microporous Tissue Interface for Improved Performance and Infection Resistance of Vascular Grafts and Other Implantable Devices (US 10,420,659) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 7 of 7
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,927,022 | Granules of porous biocompatible materials In force · From the USPTO record | In force | From the USPTO record | |
| US 8,372,423 | Implantable medical devices having microporous surface layers and method for reducing foreign body response to the same In force · From the USPTO record | In force | From the USPTO record | |
| US 8,647,393 | Implantable medical devices having microporous surface layers and method for reducing foreign body response to the same In force · From the USPTO record | In force | From the USPTO record | |
| US 12,263,077 | Vascular grafts and method for preserving patency of the same In force · From the USPTO record | In force | From the USPTO record | |
| US 10,842,916 | Injectable porous device for treatment of dry and wet age-related macular degeneration or diabetic retinopathy In force · From the USPTO record | In force | From the USPTO record | |
| US 10,420,659 | Corrugated Microporous Tissue Interface for Improved Performance and Infection Resistance of Vascular Grafts and Other Implantable Devices In force · High confidence | In force | High confidence | |
| US 10,751,203 | Corrugated Microporous Tissue Interface for Improved Performance and Infection Resistance of Vascular Grafts and Other Implantable Devices In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 no status recorded